Senior insider sale
ORIC PHARMACEUTICALS, INC. — senior position signals high conviction
$84.0K
7K shares
What this filing means
HEYMAN RICHARD A. plans to sell 7K shares of ORIC PHARMACEUTICALS, INC. valued at approximately $84.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/16/2026ACC: 0001968582-26-000036
Director
Since Apr 2020
7K
Shares to sell
$84.0K
Approx. market value
7K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/25/2016
7KTotal acquired7K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/25/2016 | Stock Option Exercise Cash | 7K | — |
| Total | 7K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
7K
Market value
$84.0K
1/16/2026
Total
Units
7K
Value
$84.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/16/2026 | 7K | $84.0K | Nasdaq | Planned |
| Total | 7K | $84.0K | ||